Researchers assessed the efficacy and cost-effectiveness of proton pump inhibitors vs surgical intervention for acid reflux control.
The prevalence of Barrett esophagus has noticeably declined in patients with gastroesophageal reflux disease (GERD) over the last 2 decades. Concurrent with this finding has been an increased trend in the use of proton pump inhibitors (PPIs) and aspirin therapy, as well as a decrease in cigarette smoking. It is therefore possible that these modifiable…
The aim of this study was to identify absolute risks and risk factors of short-term outcomes in younger patients with primary laparoscopic and secondary antireflux surgery.
A team of investigators sought to determine the ability of the Cytosponge to detect the persistence of Barrett esophagus following eradication therapy.
A team of investigators conducted a prospective, single-center, observational study at the Cleveland Clinic to determine the safety and feasibility of IT-knife tunneling and C-shaped incision endoscopic submucosal dissection of the esophagus.
Researchers aimed to describe the impact of the COVID-19 pandemic on the diagnosis of Barrett esophagus and esophagogastric cancer in Northern Ireland.
Researchers evaluated the efficacy, safety, and feasibility of concomitant transoral incisionless fundoplication to reduce symptoms of heartburn, regurgitation, and reflux.
Investigators sought to determine whether pretransplant GERD affected mortality or acute rejection rates following lung transplantation.
A team of investigators sought to assess the prevalence of Barrett esophagus in a large cohort of women with systemic sclerosis or scleroderma who underwent esophagogastroduodenoscopy.
Investigators compared the histological outcomes of endoscopic submucosal dissection with those of cap-assisted endoscopic mucosal resection.
If the current COVID-19 trends persist, the NCI estimates that the pandemic’s impact could threaten the trend of annually decreasing cancer mortality seen in the US since 1990.
Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.
Investigators assessed whether recurrent gastroesophageal junction intestinal metaplasia is associated with increased risk for subsequent dysplasia and whether endoscopic treatment lowers this risk if so.
Both cryoballoon and cryospray ablation therapies are effective in eradicating dysplastic Barrett esophagus.
Patients undergoing sleeve gastrectomy sometimes develop gastroesophageal reflux disease, a major risk factor for Barrett’s esophagus; therefore, researchers investigated whether patients with SG have a high rate of BE.
PPIs are frequently used off-label and are easily accessible as over-the-counter products, contributing to the potential for adverse events or drug-drug interactions.
In a study of kidney transplant recipients, PPI users had an almost 2-fold increased risk of mortality compared with nonusers.
Patients with Barrett’s esophagus undergoing endoscopic eradication therapy demonstrated a low rate of recurrence of intestinal metaplasia and dysplasia after complete eradication of intestinal metaplasia.
An electronic nose that measures volatile organic compounds can detect Barrett esophagus.
As a precursor to esophageal adenocarcinoma, Barrett esophagus is a crucial diagnosis for gastroenterologists to make during upper endoscopy.